Bienvenue chez nous!
Logo Ex Libris

Ethics and the Pharmaceutical Industry

  • Couverture cartonnée
  • 528 Nombre de pages
These papers by doctors, scholars, industry executives, and NGO representatives debate ethics in the pharmaceutical industry. Mich... Lire la suite
CHF 49.90
Habituellement expédié sous 3 semaines.

Description

These papers by doctors, scholars, industry executives, and NGO representatives debate ethics in the pharmaceutical industry.

Auteur

Michael A. Santoro is Associate Professor with tenure in the Business Environment Department at Rutgers Business School, where he teaches courses on business ethics, public policy, labor and human rights, law, ethical issues in the pharmaceutical industry, and China business strategy. Professor Santoro holds a Ph.D. in Public Policy from Harvard University and a J.D. from the New York University School of Law. As a Research Associate at Harvard Business School, he wrote or co-authored nearly 30 case studies and teaching notes on ethical and legal topics such as global protection of intellectual property, insider trading, the Federal Sentencing Guidelines, and the Fair Credit Reporting Act. Professor Santoro has also published numerous journal articles, op-ed articles, and book chapters on these topics in publications such as Foreign Policy, and Human Rights Quarterly. He is the author of Profits and Principles: Global Capitalism and Human Rights in China (2000). Thomas M. Gorrie is Corporate Vice President, Government Affairs & Policy at Johnson & Johnson, with responsibility as Corporate Officer for all federal, state, and international government affairs and policy. He has over 30 years of worldwide health care experience. He has worked with various Johnson & Johnson companies in research and development, marketing and sales, business development, strategic planning, general management, international venture capital, and health policy. Dr Gorrie received his Ph.D. in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich. He serves on numerous non-profit boards, including Duke University Health Care System, Robert Wood Johnson University Hospital, the Dean's Advisory Board of the Rutgers Business School, and the Hun School of Princeton.

Contenu

Charting a sustainable path for the 21st century pharmaceutical industry Michael A. Santoro; Part I. Profits, Patients' Rights, and Scientific Progress: The Ethics of Clinical Research Conducted in Private Enterprises: 1. Drug research: between ethical demands and economic constraints Jurgen Drews; 2. Emerging international norms for clinical testing: good clinical trial practice Juhana E. Idanpaan-Heikkila and Sev S. Fluss; 3. The regulatory and ethical challenges of pediatric research M. Dianne Murphy and Sara F. Goldkind; 4. Including children in research: participation or exploitation? Robert M. Nelson; 5. Racial and ethnic inclusiveness in clinical trials Valentine J. Burroughs; 6. The rights of patients to participate in clinical trials Glenna Crooks; 7. How should government regulate stem-cell research? Perspectives of a scientist-legislator The Hon. Rush Holt; Part II. Marketing and the Efficient Utilization of Healthcare Resources: Ethical and Public Policy Challenges: 8. Ethics and prescribing: the clinician's perspective Charles L. Bardes; 9. Direct-to-consumer advertising of prescription drugs: a policy dilemma Meredith B. Rosenthal and Julie M. Donohue; 10. Regulation of prescription drug promotion Thomas Abrams; 11. Off-label communications in marketing prescription drugs Scott D. Danzis; 12. The need for better health information: advancing the informed patient in Europe Don E. Detmer, Peter Singleton and Scott C. Ratzan; 13. Who should get access to which drugs? An ethical template for pharmacy benefits Norman Daniels, James E. Sabin and J. Russell Teagarden; 14. The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals Joel Hay; Part III. Patents, Pricing, and Equal Access: 15. Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities Patricia H. Werhane and Michael Gorman; 16. A future agenda for government-industry relations William Weldon; 17. AIDS activism and the pharmaceutical industry Martin Delaney; 18. The campaign against innovation Sidney Taurel; 19. Third world perspectives on global pharmaceutical access James Thuo Gathii; 20. The promise of vaccines and the influenza shortage of 2004: public and private partnerships Gary R. Noble; Part IV. Charting a Sustainable Path for the 21st Century: 21. Evolving approaches to healthcare challenges Thomas M. Gorrie; 22. Property rights in crisis: managers and rescue Nien-he Hsieh; 23. Blurring the lines: public and private partnerships addressing global health William Foege; 24. Renegotiating the grand bargain: balancing prices, profits, people, and principles Greg Koski.

Détails sur le produit

Titre: Ethics and the Pharmaceutical Industry
Auteur:
Code EAN: 9780521708883
ISBN: 978-0-521-70888-3
Format: Couverture cartonnée
Editeur: Cambridge University Press
Genre: Management
nombre de pages: 528
Poids: 764g
Taille: H227mm x B369mm x T33mm
Année: 2007